Case Study
Maria Balabanova
Localized acquired pseudoxanthoma elasticum after treatment with cream containing Striadril complex
(NACH CARE-LEITLINIE)
Keywords | Summary | Correspondence | References
Keywords
anti-wrinkle ointment, cosmetic, local irritation, pseudoxanthoma elasticum, Strivectin-SD
Schlüsselworte
Summary
Localized acquired pseudoxanthoma elasticum is a rare disorder which has similar clinical and histopathology characteristics to the inherited form of the disease except the lack of vascular and ocular involvement. Herein a clinical case of a localized acquired cutaneous pseudoxanthoma elasticum after treatment with Striadril complex-containing anti-wrinkle cream is described. The possible causative relationship between the application of the cosmeceutical and the coincidental disease development is discussed.
Zusammenfassung
Leider haben Sie sich nicht eingeloggt, um den Beitrag lesen zu können. Bitte loggen Sie sich ein oder beantragen Sie Ihre Zugangsberechtigung. Vielen Dank. Weitere Informationen finden Sie hier>
Address of Correspondence
Maria Balabanova, MD, PhD
Department of Dermatology and Venereology
Medical Faculty – Sofia
1 St. Georgi Sofiiski Blvd.
1431 Sofia, Bulgaria
maria_balabanova@yahoo.com
Conclusion
In conclusion, we describe a clinical case of a LAPXE coinciding anti-skin aging treatment with Striadril complex-containing cream.
References
1. Bercovitch L, Terry P (2004) Pseudoxanthoma elasticum. J Am Acad Dermatol 2004; 51: S13-4.
2. Hicks J, Carpenter CL, Jr, Reed RJ (1979) Periumbilical perforating pseudoxanthoma elasticum. Arch Dermatol; 115: 300-3.
3. Nielsen AO, Christensen OB, Hentzer B, Johnson E, Kobayasi T (1978) Salpeter-induced dermal changes electron-microscopically indistinguishable from pseudoxanthoma elasticum. Acta Derm Venereol; 58: 323-7.
4. Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL (2005) Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci; 27: 155-60.
5. Beer KR (2006) Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-tosevere glabellar rhytids. Dermatol Surg; 32: 184-97.